The Food and Drug Administration issued a warning in June 2011 that diabetic patients who have taken Actos and other pioglitazone-containing medicines are at a higher risk of developing bladder cancer. The warning notes that the risk is higher in patients who have taken higher dosages of Actos for more than 12 months.
France has stopped the release of these drugs. The FDA noted that it was aware of France’s decision. However, the FDA has not banned these medicines from being issued in the United States.
Gersowitz Libo & Korek, P.C. has been researching patients who have developed bladder cancer as a result of taking Actos and is now accepting new clients. If you or a loved one has fallen victim to the drug Actos, contact Gersowitz Libo & Korek, P.C. at (800) 529-9997 to learn your legal rights.
Jeep Involved in Fatal Roxbury Township Semi-Truck Accident on Interstate 80 ROXBURY TOWNSHIP, NEW JERSEY…
Silicon Valley Reeling After Google and Meta Hit With $6 Million Verdict in Historic Social…
Sightseeing Helicopter Crash Near Kalalau Beach in Hawaii Killed Three People, Including Two Residents of…
32-Year-Old Woman Killed in Sherburne Tractor-Trailer Truck Accident on State Route 12B SHERBURNE, NEW YORK…
Woman Killed, Second Woman Seriously Injured in University Heights Apartment Fire Caused by Electrical Malfunction…
Child Seriously Injured After Falling From Moving School Bus in Monsey MONSEY, NEW YORK (March…